Beijing Strong Biotechnologies Inc - Class A

SZSE:300406 (China)   Class A
Â¥ 17.31 (+0.58%) Jun 7
19.23
P/B:
2.65
Market Cap:
Â¥ 10.19B ($ 1.41B)
Enterprise V:
Â¥ 10.32B ($ 1.42B)
Volume:
3.71M
Avg Vol (2M):
5.06M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Beijing Strong Biotechnologies Inc ( SZSE:300406 ) from 2014 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Beijing Strong Biotechnologies stock (SZSE:300406) PE ratio as of Jun 08 2024 is 19.23. More Details

Beijing Strong Biotechnologies Inc (SZSE:300406) PE Ratio (TTM) Chart

To

Beijing Strong Biotechnologies Inc (SZSE:300406) PE Ratio (TTM) Historical Data

Total 1201
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Beijing Strong Biotechnologies PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-08 19.2 2024-04-01 20.9
2024-06-07 19.2 2024-03-29 21.4
2024-06-06 19.1 2024-03-28 20.7
2024-06-05 19.3 2024-03-27 21.3
2024-06-04 19.0 2024-03-26 21.7
2024-06-03 18.6 2024-03-25 21.8
2024-05-31 19.1 2024-03-22 22.5
2024-05-30 19.0 2024-03-21 22.9
2024-05-29 18.8 2024-03-20 23.3
2024-05-28 18.8 2024-03-19 23.1
2024-05-27 19.1 2024-03-18 23.6
2024-05-24 18.9 2024-03-15 24.0
2024-05-23 19.0 2024-03-14 23.7
2024-05-22 19.4 2024-03-13 23.9
2024-05-21 19.1 2024-03-12 23.8
2024-05-20 19.2 2024-03-11 23.8
2024-05-17 19.3 2024-03-08 23.5
2024-05-16 19.3 2024-03-07 23.3
2024-05-15 19.6 2024-03-06 23.9
2024-05-14 19.8 2024-03-05 23.9
2024-05-13 19.7 2024-03-04 24.5
2024-05-10 20.2 2024-03-01 24.2
2024-05-09 20.7 2024-02-29 23.6
2024-05-08 20.6 2024-02-28 22.4
2024-05-07 20.7 2024-02-27 23.1
2024-05-06 21.0 2024-02-26 22.7
2024-04-30 20.6 2024-02-23 22.2
2024-04-29 20.5 2024-02-22 22.4
2024-04-26 19.7 2024-02-21 22.3
2024-04-25 19.4 2024-02-20 22.2
2024-04-24 19.1 2024-02-19 22.4
2024-04-23 19.2 2024-02-08 22.3
2024-04-22 19.4 2024-02-07 22.2
2024-04-19 19.0 2024-02-06 21.7
2024-04-18 19.1 2024-02-05 19.8
2024-04-17 19.5 2024-02-02 18.9
2024-04-16 18.9 2024-02-01 19.3
2024-04-15 19.6 2024-01-31 19.6
2024-04-12 19.3 2024-01-30 20.4
2024-04-11 19.5 2024-01-29 21.4
2024-04-10 19.5 2024-01-26 21.9
2024-04-09 20.0 2024-01-25 22.0
2024-04-08 19.5 2024-01-24 20.5
2024-04-03 20.1 2024-01-23 20.8
2024-04-02 21.1 2024-01-22 19.8

Beijing Strong Biotechnologies Inc (SZSE:300406) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.